Sensitive and High‐Throughput Isolation of Rare Cells from Peripheral Blood with Ensemble‐Decision Aliquot Ranking
- 22 February 2012
- journal article
- research article
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 51 (19), 4618-4622
- https://doi.org/10.1002/anie.201108695
Abstract
Enrichment of cells: An approach called ensemble‐decision aliquot ranking (eDAR) for isolating rare cells from peripheral blood is described. The eDAR process has a recovery of over 93 % (number of runs n=9) with a zero false positive rate (n=8) and provides direct easy access to individual isolated live cells for downstream single‐cell manipulation and analysis (CTCs=circulating tumor cells).Keywords
This publication has 30 references indexed in Scilit:
- Translating cancer research into targeted therapeuticsNature, 2010
- Detection and HER2 Expression of Circulating Tumor Cells: Prospective Monitoring in Breast Cancer Patients Treated in the Neoadjuvant GeparQuattro TrialClinical Cancer Research, 2010
- Circulating tumour cells in clinical practice: Methods of detection and possible characterizationMethods, 2010
- Tumor metastasis: mechanistic insights and clinical challengesNature Medicine, 2006
- DETECTION OF DISSEMINATED TUMOR CELLS IN PERIPHERAL BLOODCritical Reviews in Clinical Laboratory Sciences, 2005
- Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant DiseasesClinical Cancer Research, 2004
- Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast CancerNew England Journal of Medicine, 2004
- Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences, 2003
- Circulating trophoblast in maternal bloodPrenatal Diagnosis, 2003
- Stem cells, cancer, and cancer stem cellsNature, 2001